OM:IMP A SDBMedical Equipment
Implantica (OM:IMP A SDB) Is Up 6.0% After Surgeons Endorse RefluxStop at Key Medical Meeting—Has The Bull Case Changed?
Implantica AG recently announced third quarter 2025 earnings, reporting sales of €365,000 and a net loss of €4.34 million, alongside continued rollout of its RefluxStop® device across Europe.
Recognition of RefluxStop®’s real-world success by leading acid reflux surgeons at the 2025 European Foregut Society Annual Meeting demonstrates growing clinical confidence in the device’s impact on GERD treatment.
We'll explore how strong clinical adoption at a major European conference shapes...